Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence.

Genes (Basel) · 2022 · PMC9777725 · PMID 36553635

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

suggestive but not significantno p-value reported

The analysis revealed a significant and consistent (≥2-fold change) deregulation for ten microRNAs after the treatment and suggestive but not significant deregulation for other two miRNAs ( Figure 4 A).

also in 34 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.